PACS, RIS, and CVIS | Market Insights | US | 2023
The COVID-19 global pandemic has had a negative impact on the US PACS, RIS, and CVIS market, resulting in declines in unit sales and revenue in 2020. However, following a period of recovery, the market will grow modestly through 2031, driven by the increasing movement toward value-based healthcare and effective population health management in the US, as well as continued hospital consolidation, although market saturation, healthcare system budgetary constraints, and competition from enterprise solutions will limit the pace of market expansion.
